Evogene

The Gene2Product technology consists of a number of computational genomic components, under development by Evogene, to improve the probability of successful development of biotechnology seed products.

unknown title 2011

Evogene is a world leading developer of improved plant traits, such as yield and drought tolerance, for a wide diversity of key crops through the use of plant genomics.

unknown title 2011

Evogene is collaborating with world leading seed companies to introduce its improved plant traits into key commercial crops under milestone and royalty bearing agreements.

unknown title 2011

Evogene had approximately 4.5 million publicly traded warrants outstanding, which were issued as part of its IPO on the Tel Aviv Stock Exchange in May 2007, 99.9% of which were exercised by May 31, 2011 the warrant expiry date.

unknown title 2011

These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of Evogene Ltd. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

unknown title 2011

Ofer Haviv, Evogene's president and CEO, stated: 2011 has been a year of both execution and expansion.

unknown title 2011

As of June 30, 2011, Evogene had $61.0 million in cash, cash equivalents, cash deposits and short-term marketable securities

unknown title 2011

Evogene's plant genomics capabilities combine high throughput plant validation systems, field experiments and proprietary genomic data creation.

unknown title 2011

Furthermore, we are very pleased with Evogene's current financial stability: as of June 30, 2011, we had over $60 million in cash, representing an increase of more than $25 million during the first half of 2011, including amounts received from the exercise of public warrants and the Bayer CropScience investment.

unknown title 2011

For additional information, please visit Evogene's website at www.evogene.com.

unknown title 2011